|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
3R01CA082036-10S1
|
$69,244
|
$69,244
|
Kaye, Kenneth
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
5R01CA082036-10
|
$421,279
|
$421,279
|
Kaye, Kenneth
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Polymer chelate conjugates for diagnostic cancer imaging
|
7R01CA097465-06
|
$251,200
|
$82,896
|
LU, ZHENG-RONG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Immune surveillance in murine gammaherpesvirus infection
|
2R01CA103642-06A1
|
$432,673
|
$147,109
|
Usherwood, Edward
|
DARTMOUTH COLLEGE
|
|
Viral Oncology Training Grant
|
5T32CA009111-32
|
$318,974
|
$31,897
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Targets and functions of the Kaposi's Sarcoma associated herpesvirus microRNAs
|
1K99CA137860-01A1
|
$98,753
|
$98,753
|
Gottwein, Eva
|
DUKE UNIVERSITY
|
|
Role of MAPK signaling in Kaposi's sarcoma-associated herpersvirus pathogenesis
|
5F31CA132560-02
|
$28,256
|
$28,256
|
Dyson, Ossie
|
EAST CAROLINA UNIVERSITY
|
|
The East Coast AIDS and Cancer Specimen Resource
|
5U01CA066535-15
|
$967,144
|
$241,786
|
SILVER, SYLVIA
|
GEORGE WASHINGTON UNIVERSITY
|
|
VIRUS-HOST INTERACTIONS IN CANCER
|
5T32CA009031-33
|
$301,898
|
$75,475
|
KIEFF, ELLIOTT
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
Role of KSHV in AIDS Malignancies
|
5P01CA113239-04
|
$1,152,020
|
$1,152,020
|
HAYWARD, GARY
|
JOHNS HOPKINS UNIVERSITY
|
|
Regulation of Cellular Proteins by KSHV RAP and RTA
|
5R01CA073585-13
|
$397,126
|
$397,126
|
HAYWARD, GARY
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-47S1
|
$126,362
|
$11,373
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-47S2
|
$250,000
|
$22,500
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-47S3
|
$100,000
|
$9,000
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-47
|
$7,507,885
|
$675,710
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Bim regulation by HHV-8 vIRF-1
|
5R21CA136356-02
|
$221,400
|
$221,400
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
Design of Antiviral Drugs Effective Against the HIV-1 Virus
|
ZIA BC 009101
|
$154,557
|
$77,278
|
Appella, Ettore
|
CCR (NCI)
|
|
HIV Tat Transcriptional Activation
|
ZIA BC 005753
|
$261,401
|
$52,280
|
Brady, John
|
CCR (NCI)
|
|
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs
|
ZIA BC 007363
|
$300,758
|
$255,644
|
Burke, Terrence
|
CCR (NCI)
|
|
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
|
ZIA BC 010791
|
$875,336
|
$87,534
|
Carrington, Mary
|
CCR (NCI)
|
|
Cancer risk in solid organ transplant recipients and endstage renal disease
|
ZIA CP010150-10362
|
$355,414
|
$35,541
|
Engels
|
DCEG (NCI)
|
|
HIV AIDS cancer match, U.S.
|
ZIA CP010176-10071
|
$441,575
|
$132,473
|
Engels
|
DCEG (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,416,561
|
$220,828
|
Fojo, Antonio
|
CCR (NCI)
|
|
Classical KS case-control studies
|
ZIA CP010176-10077
|
$124,626
|
$124,626
|
Goedert
|
DCEG (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$956,040
|
$95,604
|
Gottesman, Michael
|
CCR (NCI)
|
|
Molecular Therapeutics for HIV/AIDS
|
ZIA BC 010530
|
$389,883
|
$19,494
|
Hamer, Dean
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 010684
|
$1,339,887
|
$66,994
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Carbocyclic Nucleoside Isosteres as Potential Antitumor and Antiviral Agents
|
ZIA BC 006174
|
$126,285
|
$18,943
|
Marquez, Victor
|
CCR (NCI)
|
|
KSHV/HHV8 in sickle cell and other Ugandan populations
|
ZIA CP010176-10076
|
$32,969
|
$26,375
|
Mbulaiteye
|
DCEG (NCI)
|
|
KS gene expression & clonality
|
ZIA CP010176-10082
|
$3,297
|
$3,297
|
Mbulaiteye
|
DCEG (NCI)
|
|
CCR VB FACS CORE
|
ZIC BC 010936
|
$1,006,888
|
$251,722
|
McKinnon, Katherine
|
CCR (NCI)
|
|
Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors
|
ZIA BC 011105
|
$170,450
|
$64,771
|
Mitsuya, Hiroaki
|
CCR (NCI)
|
|
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors
|
ZIA BC 011109
|
$340,900
|
$34,090
|
Mitsuya, Hiroaki
|
CCR (NCI)
|
|
HIV Integrase Modeling and Computer-Aided Inhibitor Development
|
ZIA BC 010524
|
$156,919
|
$156,919
|
Nicklaus, Marc
|
CCR (NCI)
|
|
Rapid Analysis of Single Nucleotide Polymorphism Genotypes in AIDS Cohorts
|
ZIA BC 010317
|
$733,033
|
$439,820
|
O'Brien, Stephen
|
CCR (NCI)
|
|
Human Immunodeficiency Virus Epidemiology Research Study (HERS)
|
ZIA CP005782-10426
|
$24,817
|
$9,927
|
O'Brien
|
DCEG (NCI)
|
|
DNA Vaccines
|
ZIA BC 010749
|
$867,130
|
$867,130
|
Pavlakis, George
|
CCR (NCI)
|
|
HIV/AIDS Lymphomas
|
ZIA CP010176-10074
|
$181,727
|
$54,518
|
Rabkin
|
DCEG (NCI)
|
|
Molecular Diagnostics Core Laboratory
|
ZIC BC 011079
|
$371,574
|
$7,431
|
Raffeld, Mark
|
CCR (NCI)
|
|
Development of a Vaccine for HIV/AIDS: Humoral Immunity
|
ZIA BC 011058
|
$1,314,746
|
$657,373
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Development of a Vaccine for HIV/AIDS: Cellular Immunity
|
ZIA BC 011062
|
$1,314,746
|
$657,373
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Development of a Vaccine for HIV/AIDS: Translation to the Clinic
|
ZIA BC 011063
|
$292,166
|
$146,083
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Pathogenic Effects of Human Retroviruses on Hematopoietic and Adherent Cells.
|
ZIA BC 010252
|
$576,162
|
$57,616
|
Ruscetti, Francis
|
CCR (NCI)
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$327,420
|
$163,710
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Identification of Gene Polymorphisms Associated with Infectious Diseases
|
ZIA BC 010297
|
$721,060
|
$216,318
|
Winkler, Cheryl
|
CCR (NCI)
|
|
Study of tumor pathogenesis and development of therapies for AIDS-malignancies
|
ZIA BC 010885
|
$507,326
|
$304,396
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Clinical trials of patients with AIDS-related malignancies
|
ZIA BC 010888
|
$760,989
|
$380,495
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Development of Novel Therapies for HIV Infection
|
ZIA SC 006737
|
$422,772
|
$126,832
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses
|
ZIA SC 010357
|
$857,614
|
$171,523
|
Zheng, Zhi-Ming
|
CCR (NCI)
|
|
Functions of KSHV microRNAs
|
ZIA BC 011176
|
$618,420
|
$618,420
|
Ziegelbauer, Joseph
|
CCR (NCI)
|
Total relevant funding to Kaposi Sarcoma for this search: $25,155,209
|